Bolt Biotherapeutics Files 8-K on Security Holder Vote Matters
Ticker: BOLT · Form: 8-K · Filed: May 28, 2025 · CIK: 1641281
| Field | Detail |
|---|---|
| Company | Bolt Biotherapeutics, Inc. (BOLT) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, filing
Related Tickers: BOLT
TL;DR
Bolt Bio (BOLT) is having a shareholder vote on May 27th.
AI Summary
On May 27, 2025, Bolt Biotherapeutics, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware with its principal executive offices in Redwood City, California, is involved in the Pharmaceutical Preparations industry.
Why It Matters
This filing signals that Bolt Biotherapeutics is engaging its shareholders in a decision-making process, which could impact the company's future direction or governance.
Risk Assessment
Risk Level: low — The filing is a routine procedural report regarding a vote of security holders and does not disclose any immediate financial or operational risks.
Key Numbers
- 001-39988 — SEC File Number (Identifies the company's filing with the SEC.)
- 47-2804636 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Bolt Biotherapeutics, Inc. (company) — Registrant
- May 27, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Redwood City, California (location) — Principal Executive Offices
- 2834 (industry_code) — Standard Industrial Classification
FAQ
What specific matters are being submitted for a vote of security holders?
The filing does not specify the exact matters to be voted on, only that such matters are being submitted.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 27, 2025.
What is Bolt Biotherapeutics, Inc.'s Standard Industrial Classification code?
The SIC code for Bolt Biotherapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Where are Bolt Biotherapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 900 Chesapeake Drive, Redwood City, California, 94063.
Is this filing related to a change in the company's name or address?
The filing notes a former name, 'Bolt Therapeutics, Inc.', with a date of name change as May 4, 2015, but the current report does not indicate a recent name or address change.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Bolt Biotherapeutics, Inc. (BOLT).